http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2571288-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f557e4a9244e2362466d42f31322efdc |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36 |
filingDate | 2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c9f478d7334bd3de0f5713aab474bb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10861f9fdfde27630ad7a6f02a879068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11b31b8fa57a0824108bc03531dff1b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b006c5c382b9b26c193f19917056c91 |
publicationDate | 2015-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2571288-C1 |
titleOfInvention | Method for producing ex vivo soluble fibrinogen |
abstract | FIELD: medicine. n SUBSTANCE: fresh-frozen plasma is unfrozen and centrifuged; the produced cryoprecipitate is solubilised and treated with aluminium hydroxide; the produced suspension is centrifuged; the produced deposit containing non-target proteins are rejected; the supernatant is treated with polyethylene glycol; the suspension is centrifuged; the supernatant is rejected; the deposit is solubilised and subject to viral inactivation, cleaned from viral inactivation products by shaking with Vaseline oil and re-precipitating with glycerol; the deposit procedure is repeated twice; the produced fibrinogen solution is bottled and lyophilised. n EFFECT: producing fibrinogen, which possesses fast solubility. n 2 ex, 2 dwg, 3 tbl |
priorityDate | 2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.